Natco Pharma appoints Dr. Pavan Ganapati Bhat as Executive Director
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Lupin is the 6th largest company in the Indian Pharmaceutical Market
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
Manish led SeQuent since 2014 and played a major role in transforming the company
Subscribe To Our Newsletter & Stay Updated